Clinical Trials Logo

Insulin Resistance clinical trials

View clinical trials related to Insulin Resistance.

Filter by:

NCT ID: NCT01124487 Completed - Lipid Profile Clinical Trials

The Acute Effects of Oleic Acid Enriched-diets on Lipids, Insulin Sensitivity and Serum Inflammatory Markers

Start date: August 2009
Phase: N/A
Study type: Interventional

Objectives: To investigate the acute effects of olive oil, palm olein and lard on lipid profile, insulin sensitivity and inflammatory markers. Hypothesis: Different dietary fats will alter lipid profile, insulin sensitivity and inflammatory markers postprandially.

NCT ID: NCT01122641 Completed - Insulin Resistance Clinical Trials

The Vascular Effects of Vildagliptin in Insulin Resistant Individuals

Start date: May 2010
Phase: Phase 3
Study type: Interventional

Animal models have demonstrated that incretins have a glucose-independent effect on vascular perfusion, and there is limited evidence that incretins may enhance endothelial function in healthy subjects. Currently DPP-4 inhibition increases levels of the endogenous incretin Glucagon-like Peptide 1 (GLP-1) and is licensed for the treatment of hyperglycaemia in type 2 diabetes. They are positioned as third or even fourth line therapy after metformin, sulphonylureas ± glitazones, however recent analyses of cardiovascular outcomes in glitazones and sulphonylureas suggest at best they do not reduce cardiovascular endpoints, and may increase some outcomes. If the vascular benefits suggested in animal models are realised in humans this should see the DPP-4 inhibitors moved to second line and possibly 1st line. In order to realise the potential the investigators would like initially to demonstrate increases in vascular perfusion and function in a placebo controlled trial using accurate surrogates for vascular function in patients with insulin resistance and obesity. The investigators hypothesis is that by increasing incretin activity in insulin resistant states the investigators will lower capillary pressure and improve microvascular function, which will be accompanied by a reduction in macular thickness (by reducing macular oedema) and microalbuminuria, recognised surrogates for early diabetic retinopathy and renal failure respectively.

NCT ID: NCT01121172 Completed - Obesity Clinical Trials

Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ)

Start date: May 2010
Phase: N/A
Study type: Observational

The aim of this study is to investigate serum apelin levels as well as their possible association with G212A polymorphism of the apelin receptor in obese children and adolescents. So far apelin has been reported to be involved in the pathophysiology of various heart diseases such as cardiomyopathies and heart failure. According to recent reports in adults apelin seems to be associated with impaired glucose metabolism, particularly in newly diagnosed diabetes type 2 patients. Obesity is associated with insulin resistance and compensatory hyperinsulinemia leading to diabetes mellitus type 2 even in youngsters. The researchers will try to investigate the role of this new adipokine in order to early detect and to prevent similar entities in childhood obesity.

NCT ID: NCT01119196 Completed - Clinical trials for End Stage Renal Disease

The Measurement of Insulin Resistance in Peritoneal Dialysis Patients

Start date: September 2010
Phase: N/A
Study type: Interventional

The goal of this study is to examine the relevance of insulin resistance in peritoneal dialysis (PD) patients as well as the means to improve this metabolic derangement. We will do so through a prospective randomized study using Icodextrin as an alternate dialysate solution to routine glucose-based dialysate. We hypothesize that (1) the glucose loading associated with PD leads to impairment in insulin sensitivity, (2) the degree of insulin resistance is dependent on the basal metabolic state (fasting versus stimulated), and (3) the replacement of conventional dialysate with glucose-sparing dialysate preparations will improve insulin resistance and associated metabolic disturbances in PD patients.

NCT ID: NCT01112007 Completed - Hypertension Clinical Trials

Accomplices of Insulin Resistance in Prehypertension: Aldosterone?

Start date: April 2010
Phase: N/A
Study type: Observational

The purposes of the study are to evaluate the relative contributions of insulin resistance and renin-angiotensin-aldosterone system to blood pressure (BP) in subjects with prehypertension. This is a cross-sectional study. Anthropometric and BP measurements will be performed in 50 prehypertensive subjects. The subjects will receive a 75-g oral glucose tolerance test and a postural stimulation test for the measurements of insulin resistance, plasma rennin concentration and aldosterone level. Log (ISI0,120), an insulin sensitivity index from the oral glucose tolerance test, will be calculated. Statistical analyses will be performed to compare the degree to which aldosterone and Log (ISI0,120) predicted systolic and diastolic BP in these prehypertensive subjects.

NCT ID: NCT01106313 Completed - Depression Clinical Trials

Insulin Resistance in Patients With Major Depression

Start date: July 2009
Phase: N/A
Study type: Observational

The purpose of this study is to study the relationship between insulin and glucose action and neuropsychological functioning (memory, attention, general thinking abilities) in persons with depression.

NCT ID: NCT01105143 Completed - Obesity Clinical Trials

Effects of Negative Energy Balance on Muscle Mass Regulation

Start date: March 2012
Phase: N/A
Study type: Interventional

The investigators here propose to perform a prospective randomized intervention trial in post-menopausal women to investigate the endocrine network, which contributes to the changes in skeletal muscle mass during weight loss.

NCT ID: NCT01103921 Completed - Metabolic Syndrome Clinical Trials

The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks

DRS
Start date: October 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effects of consumption of sugar-sweetened beverages on blood triglycerides and cholesterol, cholesterol concentrations, and the body's sensitivity to insulin.

NCT ID: NCT01093651 Completed - Diabetes Clinical Trials

Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV

DPPIVinHIV
Start date: June 2010
Phase: Phase 2/Phase 3
Study type: Interventional

We will test the safety of a new class of anti-diabetes compounds (DPPIV-inhibitors) in people living with HIV. Future trials will examine efficacy for treating diabetes and reducing cardiovascular disease risk in people living with HIV.

NCT ID: NCT01093417 Completed - HIV Infections Clinical Trials

Study of Vitamin D and Effect on Heart Disease and Insulin Resistance

Start date: January 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate how Vitamin D affects endothelial function, inflammation, lipids, insulin resistance, vitamin D levels, and PTH.